Faronem CV Tablet is a combination antibiotic containing Faropenem 200mg and Clavulanic Acid 125mg, designed to treat a broad spectrum of bacterial infections. Faropenem, a beta-lactam antibiotic from the penem group, exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis, effectively targeting both gram-positive and gram-negative bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing the enzymatic degradation of Faropenem by resistant bacteria, thereby enhancing its efficacy against beta-lactamase producing strains. This synergistic combination is particularly useful in managing respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections where resistance to standard antibiotics is a concern. Faronem CV Tablet is typically prescribed based on culture and sensitivity tests to ensure optimal therapeutic outcomes. It is generally well-tolerated, but patients should be monitored for potential side effects such as gastrointestinal disturbances, allergic reactions, or hypersensitivity. Caution is advised in individuals with a history of penicillin allergy. The medication should be taken as directed by a healthcare professional, completing the full course to prevent resistance development and recurrence of infection. Faronem CV Tablet offers an effective treatment option for complicated infections requiring broad-spectrum coverage.